Application
ATP6V1E2 Antibody (Center) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the ATP6V1E2 antibody detected the ATP6V1E2 protein (arrow).Application
ATP6V1E2 Antibody (Center) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | ATP6V1E2 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | ATP6E1, ATP6EL2, ATP6V1EL2 |
|---|---|
| Alternative Names | ATP6V1E2 ATP6E1 ATP6EL2 ATP6V1EL2 V-type proton ATPase subunit E 2 Vacuolar proton pump subunit E 2 |
| Molecular Weight(MW) | 26074 Da |
| Function | Subunit of the peripheral V1 complex of vacuolar ATPase essential for assembly or catalytic function. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells. This isoform is essential for energy coupling involved in acidification of acrosome (By similarity) |
| Tissue Specificity | Testis specific. |
| Entrez Gene | 90423 |
|---|---|
| Nucleotide Accession | NP_542384.1 |
Application
ATP6V1E2 Antibody (Center) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the ATP6V1E2 antibody detected the ATP6V1E2 protein (arrow).
Application
ATP6V1E2 Antibody (Center) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
